Takezaki, T., Ota, K., Kuroda, J., Shinojima, N., Takeshima, Y., Matsuura, J., . . . Mukasa, A. (2020). ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma. Neurooncol Adv.

Takezaki, Tatsuya, Kazutaka Ota, Junichiro Kuroda, Naoki Shinojima, Yuki Takeshima, Jin Matsuura, Takahiro Yamamoto, Keishi Makino, a Akitake Mukasa. "ML-20 Outcome of High-dose Methotrexate-based Chemotherapy With or Without Rituximab for Primary Central Nervous System Lymphoma." Neurooncol Adv 2020.

Takezaki, Tatsuya, et al. "ML-20 Outcome of High-dose Methotrexate-based Chemotherapy With or Without Rituximab for Primary Central Nervous System Lymphoma." Neurooncol Adv 2020.